- Home
- ICCT vs XXII Comparison
ICCT vs XXII Comparison
Compare ICCT & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCT
- XXII
- Stock Information
- Founded
- ICCT 1992
- XXII 1998
- Country
- ICCT United States
- XXII United States
- Employees
- ICCT N/A
- XXII N/A
- Industry
- ICCT Computer Software: Prepackaged Software
- XXII Medicinal Chemicals and Botanical Products
- Sector
- ICCT Technology
- XXII Health Care
- Exchange
- ICCT Nasdaq
- XXII Nasdaq
- Market Cap
- ICCT 4.1M
- XXII 3.9M
- IPO Year
- ICCT N/A
- XXII N/A
- Fundamental
- Price
- ICCT $0.19
- XXII $4.87
- Analyst Decision
- ICCT
- XXII
- Analyst Count
- ICCT 0
- XXII 0
- Target Price
- ICCT N/A
- XXII N/A
- AVG Volume (30 Days)
- ICCT 17.9M
- XXII 9.7M
- Earning Date
- ICCT 11-19-2024
- XXII 11-12-2024
- Dividend Yield
- ICCT N/A
- XXII N/A
- EPS Growth
- ICCT N/A
- XXII N/A
- EPS
- ICCT N/A
- XXII N/A
- Revenue
- ICCT $11,049,477.00
- XXII $17,304,000.00
- Revenue This Year
- ICCT N/A
- XXII $56.94
- Revenue Next Year
- ICCT N/A
- XXII $2.98
- P/E Ratio
- ICCT N/A
- XXII N/A
- Revenue Growth
- ICCT 42.66
- XXII N/A
- 52 Week Low
- ICCT $0.15
- XXII $3.90
- 52 Week High
- ICCT $2.31
- XXII $581.85
- Technical
- Relative Strength Index (RSI)
- ICCT 41.62
- XXII 18.51
- Support Level
- ICCT $0.15
- XXII $3.90
- Resistance Level
- ICCT $0.34
- XXII $12.29
- Average True Range (ATR)
- ICCT 0.03
- XXII 1.06
- MACD
- ICCT 0.00
- XXII -0.59
- Stochastic Oscillator
- ICCT 6.01
- XXII 4.36
About ICCT iCoreConnect Inc. Common stock
iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.